Consensus Xbrane Biopharma AB

Equities

XBRANE

SE0007789409

Market Closed - Nasdaq Stockholm Other stock markets 16:29:43 29/04/2024 BST			5-day change	1st Jan Change
0.208 ^SEK	-2.58%		-11.49%	-97.92%

04-22	Transcript : Xbrane Biopharma AB - Special Call
03-18	Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index	CI

Evolution of the average Target Price on Xbrane Biopharma AB

Price target over the last 5 years

History of analyst recommendation changes

a1353012f58775629.cI7yCe5UMVopXg7d1l-Qu0AjzfEHoRsvedmv0YaYwh4.Mve_fdsefgt7PFiujir49zFooMZ3kHh2K4jc5LbMm04z_5VvoGwCHR89Vw~478c92a5670c182186aa4deff07fe8fe

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.2135 SEK

Average target price

0.625 SEK

Spread / Average Target

+192.74%

High Price Target

0.65 SEK

Spread / Highest target

+204.45%

Low Price Target

0.6 SEK

Spread / Lowest Target

+181.03%

Consensus detail

Consensus revision (last 18 months)

Ratings for Xbrane Biopharma AB

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar